The Cystic Fibrosis Foundation is investing up to $2 million in Nanite to develop new non-viral methods of…
Joana Vindeirinho, PhD
Joana is a Science Writer at BioNews. She is a cell biologist with a PhD in neurobiology of disease (University of Coimbra, Portugal), focused on the role of the adenosinergic system in the early stages of diabetic retinopathy. She moved from research into high-impact medical editing in 2017, before shifting into a more direct science writing and communication role in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Joana Vindeirinho, PhD
Type 2 diabetes in a 49-year-old woman with cystic fibrosis (CF) went into remission after bariatric surgery, given to…
CFTR gene mutations — the cause of cystic fibrosis (CF) — significantly reduce the cell entry and replication of…
People with cystic fibrosis (CF) and advanced lung disease who have bacterial communities dominated by just one type of…